Gene · 6196
Papers2,567
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 2,567
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A11 Peptide Enhances Radiosensitivity by Degrading EphA2 in Nasopharyngeal Carcinoma. | Cancer Sci | 2026 | 41387202 | PubTator, text mining | PubMed |
| Development of a lactylation-related molecular classification and machine learning-based gene signature to predict survival, response to immunotherapy for ovarian cancer. | Pathol Res Pract | 2026 | 41371064 | PubTator, text mining | PubMed |
| The Roles of TOPK in Tumorigenesis and Development: Structure, Mechanisms, Pathways, and Therapeutic Implications. | Int J Biol Sci | 2026 | 41362722 | PubTator, text mining | PubMed |
| Zinc finger protein 514 promotes esophageal cancer progression by enhancing cell proliferation, migration and invasion. | Mol Med Rep | 2026 | 41170736 | PubTator, text mining | PubMed |
| miR-512-3p/RPS6KA2 Axis Regulates Cisplatin Resistance in Ovarian Cancer via Autophagy and Ferroptosis. | Oncol Res | 2025 | 41502518 | PubTator, text mining | PubMed |
Functional Assessment of Genetically Modified Infrapatellar Fat Pad Mesenchymal Stem/Stromal Cell-Derived Extracellular Vesicles (EVs): Potential Implications for Inflammation/Pain Reversal in Osteoarthritis. | Cells | 2025 | 41439971 | PubTator, text mining | PubMed |
| Cardiovirus-Mediated PKR inhibition results from nucleocytoplasmic trafficking disruption. | PLoS Pathog | 2025 | 41406153 | PubTator, text mining | PubMed |
| Natural compounds from traditional Chinese medicine regulating stem cell fate: Identification and therapeutic potential. | Chin Herb Med | 2025 | 41399795 | PubTator, text mining | PubMed |
| ETV1 orchestrates a self-reinforcing ERK1/2-RSK3 signaling loop to drive atrial fibrillation pathogenesis: implications for targeted therapy. | Sci Rep | 2025 | 41345483 | PubTator, text mining | PubMed |
| Long-term dynamic profiles of cognitive kinases induced by different learning protocols. | Learn Mem | 2025 | 41285589 | PubTator, text mining | PubMed |
| ORF45-induced Filamin A phosphorylation promotes cell motility and cell-contact dependent viral infection of Kaposi's sarcoma-associated herpesvirus. | PLoS Pathog | 2025 | 41284726 | PubTator, text mining | PubMed |
| Long-term dynamic profiles of cognitive kinases induced by different learning protocols. | bioRxiv | 2025 | 41279686 | PubTator, text mining | PubMed |
| Disease-specific alterations of the enteric nervous system in precancerous colonic mucosa and their implications for mucin regulation. | Sci Rep | 2025 | 41258027 | PubTator, text mining | PubMed |
| RSK Inhibition Rewires Kinase Networks and Triggers Cascading Pathway Disruption in Esophageal Cancer. | J Proteome Res | 2025 | 41157826 | PubTator, text mining | PubMed |
| Allosteric SHP2 inhibitors suppress lung cancer cell migration by inhibiting non-canonical activation of EphA2 via the ERK-RSK signaling pathway. | Sci Rep | 2025 | 41125616 | PubTator, text mining | PubMed |
| Selective EV Protein Sorting and Pathway Perturbation in AML Upon Synergistic FLT3 and Hedgehog Pathway Inhibition. | J Extracell Vesicles | 2025 | 40985884 | PubTator, text mining | PubMed |
| The leader proteins of Theiler's virus and Boone cardiovirus use a combination of short linear motifs (SLiMs) to target RSK kinases to the nuclear pore complex. | J Virol | 2025 | 40928249 | PubTator, text mining | PubMed |
| PTPN22-CD45 dual phosphatase retrograde feedback enhances TCR signaling and autoimmunity. | Sci Adv | 2025 | 40911684 | PubTator, text mining | PubMed |
| Inhibition of YB-1 phosphorylation enhances cisplatin activity and disrupts cell division in pleural mesothelioma. | Br J Cancer | 2025 | 40908296 | PubTator, text mining | PubMed |
| Local abaloparatide administration promotes in situ alveolar bone augmentation via FAK-mediated periosteal osteogenesis. | Int J Oral Sci | 2025 | 40890141 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6196/papers?page=3